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ABSTRACT
Diabetes disease management (DM) programs strive to promote healthy behaviors, includ-
ing obtaining hemoglobin A1c (A1c) and low-density lipoprotein (LDL) tests as part of stan-
dards of care. The purpose of this study was to examine the relationship between frequency
of telephonic contact and A1c and LDL testing rates. A total of 245,668 members continuously
enrolled in diabetes DM programs were evaluated for performance of an A1c or LDL test dur-
ing their first 12 months in the programs. The association between the number of calls a mem-
ber received and clinical testing rates was examined. Members who received four calls dem-
onstrated a 24.1% and 21.5% relative increase in A1c and LDL testing rates, respectively,
compared to members who received DM mailings alone. Response to the telephonic inter-
vention as part of the diabetes DM programs was influenced by member characteristics in-
cluding gender, age, and disease burden. For example, females who received four calls
achieved a 27.7% and 23.6% increase in A1c and LDL testing, respectively, compared to fe-
males who received mailings alone; by comparison, males who were called achieved 21.2%
and 19.9% relative increase in A1c and LDL testing, respectively, compared to those who re-
ceived mailings alone. This study demonstrates a positive association between frequency of
telephonic contact and increased performance of an A1c or LDL test in a large, diverse dia-
betes population participating in DM programs. The impact of member characteristics on the
responsiveness to these programs provides DM program designers with knowledge for de-
veloping strategies to promote healthy behaviors and improve diabetes outcomes. (Disease
Management 2007;10:101–109)
101
INTRODUCTION
NATIONAL STATISTICS for 2005 report that 20.8million people—7% of the US popula-
tion—have diabetes. Total costs attributed to
the condition topped $132 billion in 2002.1
There is abundant evidence that improving
glycemic control creates benefits for persons
1Healthways, Inc., Nashville, Tennessee.
2Department of Health Policy, Jefferson Medical College, Philadelphia, Pennsylvania.
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with diabetes by decreasing short- and long-
term diabetes complications and lowering dia-
betes-related costs.2–5 In general, for every per-
centage point drop in hemoglobin A1c (A1c; eg,
from 8% to 7%), there is a corresponding re-
duction of 40% in the risk of microvascular
complications (eg, retinopathy, kidney failure,
peripheral neuropathy).2
Type 2 diabetes is associated with a two- to
fourfold excess risk of cardiovascular disease
(CVD). This is of particular importance as CVD
is the major cause of death in patients with type
2 diabetes.6 Numerous studies have identified
cholesterol (ie, low-density lipoprotein [LDL],
high-density lipoprotein [HDL], and triglyc-
erides) as an independent predictor of CVD.7,8
These and other studies suggest that improved
cholesterol control can reduce cardiovascular
complications 20%–50%.9
Because of the significant risks of uncon-
trolled blood sugar and lipids for people with
diabetes, the American Diabetes Association
(ADA) calls for A1c testing at least twice a year
for patients meeting glycemic control treatment
goals, and quarterly testing for patients not
meeting these goals. The ADA also calls for
lipid testing at least annually.10 Adherence to
these guidelines is critical for appropriate dis-
ease management (DM) and to reduce the risk
of diabetes exacerbations. Studies have dem-
onstrated that patients who obtain regular clin-
ical tests are more likely to improve poor gly-
cemic levels and achieve metabolic control.11–13
A key focus of diabetes DM programs is mo-
tivating members toward healthy behaviors,
including obtaining recommended clinical
tests. Results of a recent Healthways study
demonstrated an association between patient
participation in their diabetes DM programs
and a measurable improvement in A1c test-
ing.14 Other studies in the DM literature also
speak to the positive impact of diabetes DM on
frequency of testing and promotion of healthy
behaviors directed toward improved control of
diabetes.15–17 Less is known about which spe-
cific components of DM programs drive the im-
proved outcomes. For instance, telephonic in-
tervention through clinician-staffed call centers
is believed to be an important component of
the overall strategy to educate members, en-
courage self-management, and identify oppor-
tunities for improving care delivery and coor-
dination. However, there is little published 
information on the impact of telephonic inter-
vention on driving large, diverse diabetes pop-
ulations toward achieving the overall goals of
diabetes DM.
The purpose of this retrospective observa-
tional study was to determine the relationship
between frequency of telephonic contact and
performance of recommended A1c and LDL
testing in a large, multiregional, multi-health
plan diabetes DM program. Several unique fea-
tures of this study demonstrate the significance
of these findings to other DM programs. Broad
applicability and large population sample size
were priorities in designing the study, ensur-
ing that the approach would be useful in fu-
ture analyses of DM programs targeting other
chronic conditions. Further, members were
grouped together based on the amount of time
that they were exposed to DM as opposed to
evaluating different DM calendar or contrac-
tual years. This approach allowed a more con-
sistent evaluation of program effect based on
length of participation in the program. In ad-
dition, this study sought to identify variations
in clinical testing rates with respect to age, gen-
der, and/or burden of disease in order to bet-
ter understand how population diversity may
impact healthy behaviors.
METHODS
Healthways diabetes disease management 
program overview
The diabetes DM programs were designed to
work collaboratively and proactively with per-
sons with diabetes, via telephone and mail, to
ensure that each member understands his or
her condition and the reasons for adhering to
standards of care and treatment regimens. Par-
ticipation in the programs is an “opt-out” or
engagement process whereby health plan
members with diabetes are automatically en-
rolled in the DM programs with the right to de-
cline participation at any time. Telephone calls
on behalf of members under the age of 18 are
COBERLEY ET AL.102
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directed to a parent or legal guardian unless
the parent gives permission for the child to re-
ceive the call directly. Similarly, elderly or dis-
abled members may give approval for a rela-
tive or caregiver to receive calls on their behalf.
The call centers in this study were staffed
with highly experienced clinicians (ie, regis-
tered nurses, registered dieticians) who initi-
ated and maintained telephonic relationships
with DM program members. Telephonic mem-
ber support included several types of phone
calls including introductory welcome calls, reg-
ularly scheduled care calls based on level of
disease severity, and reminder calls regarding
standards of care. Mail interventions included
quarterly newsletters, reminder mailings, and
disease-specific educational materials. Follow-
ing introduction letters to the members and
their corresponding physicians, welcome pack-
ets containing a detailed explanation of the pro-
gram were mailed to members. Additional ed-
ucational materials were mailed to members as
needed.
Study population
A standardized outcomes data set was de-
veloped from a multiregional population of di-
abetes DM program members. The study pe-
riod was defined as January 1, 2001 through
December 31, 2004. This data set encompassed
245,668 unique members with diabetes from 25
different health plans across the United States.
A key design feature was standardization of
the data, that is, replacing the health plan–spe-
cific contract or business logic with uniform cri-
teria for eligibility, costs, and metrics. Using
Structured Query Language (SQL), a large
standardized Oracle 9i database was queried to
identify members who were continuously en-
rolled in their first 12 months of the diabetes
DM programs. For the purpose of this study,
members were grouped together based on the
number of months they participated in DM
programs, irrespective of the contract year.
This grouping was performed to account for
the fact that in any given DM program contract
year, members will have participated in the
programs for varying periods of time. By
grouping members in this way, it is possible to
more uniformly account for varying lengths of
participation in the DM programs.
Clinical testing
Two clinical process metrics—A1c and LDL
testing—were examined to measure adherence
to standards of care relative to the number of
telephonic interventions received by a member
during their first 12 months in the program.
The primary outcome variables were whether
members had an A1c or an LDL test during 
the same 12-month period. In order to be as
conservative as possible, only administrative
claims data were evaluated for A1c or LDL test-
ing; self-reported data were not used in this
study.
Response to telephonic intervention
Health plans selected which particular DM
intervention packages their members received,
which determines the level of telephonic con-
tact. For instance, one DM intervention pack-
age only targeted members with the greatest
disease burden (ie, top 20% of the population)
to receive calls, while the remaining members
only received one welcome call. In contrast, an-
other DM intervention package targeted all
members to receive four standard of care calls
per year. The results of this study represent an
aggregate of all the DM interventions, con-
tributing to even greater population diversity.
The A1c and LDL testing rates of members
in response to telephonic interventions during
their first year in the DM programs were as-
sessed. Members were grouped into cohorts
based on the number of calls received during
their first 12 months of the DM intervention.
The number of calls received ranged from zero
(primarily due to inaccurate phone numbers)
to four calls. The A1c testing rate was calcu-
lated for each of these cohorts as the number
of eligible members (the denominator) who
had at least one A1c test during the 12-month
period (the numerator), as evidenced by ad-
ministrative claims data indicating an A1c test.
The LDL testing rates for each cohort were sim-
ilarly calculated. The testing rates were then
plotted against the number of calls received.
Because the DM programs address both type 1
TELEPHONIC INTERVENTION AND IMPROVED CLINICAL TESTING 103
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and type 2 diabetes, these populations were not
analyzed separately.
Member characteristics
Because gender, age, and disease burden are
recognized as variables with potential influ-
ence on DM outcomes, these were also evalu-
ated as part of the study. Disease burden was
estimated based on the amount of healthcare
resources a member utilized and expressed as
a resource utilization band (RUB) score rang-
ing from zero (no utilization) to five (highest
utilization) using the Johns Hopkins ACG
tool.18 A RUB score was calculated for each
member based on healthcare utilization during
the first 12 months in a DM program.
RESULTS
A total of 245,668 members continuously en-
rolled in diabetes DM programs for a consecu-
tive 12-month period were identified. Members
were grouped by their first 12 months in the
DM program, irrespective of contract year. The
study population was 46.0% female and 54.0%
male. The average age was 52.6 years. The av-
erage RUB score (disease burden) was 3.03. Of
the 245,668 members, 137,921 (56.1%) had at
least one A1c test in the first 12 months of par-
ticipation, and 117,765 (47.9%) had at least one
LDL test.
In general, the greater the number of calls re-
ceived by members during their first 12 months
of DM program participation, the greater the
A1c and LDL testing rates (Fig. 1). Members
who received four calls demonstrated a 24.1%
and 21.5% relative increase in A1c and LDL
testing rates, respectively, compared to mem-
bers who received DM mailings alone (zero call
group; Fig. 1). Overall, A1c testing rates were
greater than LDL testing rates regardless of the
number of calls received.
While the total population demonstrated im-
provement in both metrics, gender influenced
A1c and LDL testing rates. Typically, females
who received mail alone were less likely to ob-
tain recommended tests than males who only
received DM mailings (Fig. 2). However, fe-
males were more responsive than males to the
calls. Females who received four calls achieved
a 27.7% and 23.6% relative increase in A1c and
LDL testing, respectively, compared to females
receiving mail alone. This level of increase was
in contrast to the respective 21.2% and 19.9%
relative increase obtained by males who re-
ceived calls. Therefore, as frequency of calls in-
creased so did testing rates for females, even-
tually matching or exceeding testing rates
obtained by males.
A1c and LDL testing rates also varied by age.
Members in the younger group (age 0–19) were
more responsive to calls and eventually had
markedly higher testing rates than members in
other age categories. Younger members called
four times achieved a 58.4% relative increase in
A1c testing compared to younger members re-
ceiving mail alone (Fig. 3). Of members who re-
ceived four calls, the 20–64 and 65 or older
groups obtained 25.0% and 33.8% relative in-
COBERLEY ET AL.104
FIG. 1. A1c and LDL testing rates by number of calls.
FIG. 2. A1c and LDL testing rates by gender and by call
volume.
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creases, respectively, in A1c testing compared
to the members receiving mail alone.
LDL testing also was influenced by age
group, but the effect differed from that ob-
served when examining A1c testing. Members
in the 20–64 age group demonstrated the high-
est LDL testing rates overall. In addition, mem-
bers aged 20–64 who received four calls
achieved a 23.2% relative increase in LDL test-
ing compared to members receiving mail alone
(Fig. 4). While members in the 65 or older age
group were less likely to have an LDL test than
those in the 20–64 age group, the members in
the 65 or older group demonstrated similar lev-
els of improvement. Members in the 65 or older
group who received four calls demonstrated a
24.3% relative increase in testing compared to
members receiving mail alone. The youngest
members (0–19 years of age) had the lowest
LDL testing rate, in sharp contrast to what was
observed for A1c testing. However, members
ages 0–19 who received four calls achieved the
greatest improvement in LDL testing overall
and obtained a 48.1% relative increase com-
pared to members in this age group who were
receiving mail alone.
An association was observed between A1c
and LDL testing rates and disease burden, ex-
pressed as a RUB score. Members with low dis-
ease burden (RUB 0 and RUB 1) had the low-
est A1c and LDL testing rate (Fig. 5); however,
the members with the lowest disease burden
(RUB 0) demonstrated the greatest improve-
ment in A1c and LDL testing in response to
calls. Members with the lowest disease burden
who received four calls demonstrated 377%
and 488% improvement in A1c and LDL test-
ing, respectively, compared to members re-
ceiving mail alone.
Members with severe disease burden (RUB
4 and RUB 5) had the highest overall testing
rates, but achieved more modest improvement
in A1c and LDL testing (Fig. 6). High disease
burden members with diabetes who received
four calls obtained a 12.2% and 11.5% relative
increase in A1c and LDL testing compared to
members receiving mail alone.
DISCUSSION
This study represents a large-scale and use-
ful approach to understanding DM program
outcomes and how these outcomes may vary
based on population diversity. There are sev-
eral distinguishing features of the approach
adopted in this study. One key feature was the
examination of outcomes and patterns in a
uniquely large diabetes DM population that in-
cluded members from multiple and geograph-
ically diverse health plans. This methodology
allowed for a more generalizable interpretation
of results across various health plans with dif-
ferent benefit structures and employer types.
An additional feature was the grouping of
members into cohorts based on their first 12
months of program participation, irrespective
of contract or calendar year. By grouping mem-
bers together in this manner, the influence of
trends in clinical testing occurring in a given
calendar year was minimized. The result was
the ability to examine improvement in A1c and
TELEPHONIC INTERVENTION AND IMPROVED CLINICAL TESTING 105
FIG. 3. A1c testing rates by age and call volume.
FIG. 4. LDL testing rates by age and by call volume.
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LDL testing achieved by members participat-
ing in DM programs, while minimizing the im-
pact of individual health plan variability or an-
nual healthcare trends.
Analysis of this large diabetes DM program
population demonstrated increases in A1c and
LDL testing in the first 12 months of participa-
tion in the program. A dose-response effect was
observed between volume of calls and A1c or
LDL testing. Specifically, the call volume was
positively associated with increases in testing.
A member’s outlook or receptiveness to DM
may have influenced this relationship. For ex-
ample, members who received or accepted
more calls may have been more motivated to-
ward healthy behaviors than members who re-
ceived or accepted fewer calls. Future studies
will evaluate members’ characteristics to assess
whether factors potentially influencing adher-
ence to clinical testing can be identified and
measured.
In general, A1c testing rates were higher than
LDL testing rates. Age was one variable that
influenced responsiveness to the DM program.
Specifically, the A1c testing rates obtained by
members in the 20–64 and 65 or older age
groups differed by 3.6%–9.2% compared to
LDL testing rates. This may indicate a broader
awareness and acceptance of A1c as the previ-
ous gold standard test for diabetes monitoring.
The more recently added guideline for LDL
testing does not appear to have achieved such
standing, despite its importance as part of stan-
dards of care for diabetes.8,10 Most striking was
the difference in A1c and LDL testing rates for
the youngest member group (ages 0–19). The
A1c testing rates obtained by members in the
0–19 age group differed within call cohorts by
30.3%–49.5% compared to LDL testing rates ob-
tained by members in this same age group.
Paradoxically, while the youngest members
demonstrated the highest overall A1c testing
rates and the greatest improvement in A1c test-
ing compared to the other age groups, they also
COBERLEY ET AL.106
FIG. 5. A1c and LDL testing rates by lower disease burden (RUB) and by call volume.
FIG. 6. A1c and LDL testing rates by higher disease burden (RUB) and by call volume.
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had the lowest LDL testing rate compared to
the other age groups. This is of concern because
hyperlipidemia, specifically elevated LDL lev-
els, is common in children and adolescents
with type 1 diabetes, and children and adoles-
cents with elevated LDL levels have been re-
ported to have significantly higher A1c levels.19
The results of this study suggest that additional
efforts be made to address the importance of
LDL testing in general, and that emphasis
should be placed on communication with the
youngest age groups or their parents.
The potential of DM programs to assist in im-
proving adherence to clinical testing for elderly
populations is promising. The quality of care
received by elderly Medicare patients with di-
abetes is suboptimal; beneficiaries are less
likely to obtain A1c testing.20,21 Recently, fed-
eral government-sponsored awards have been
received by several DM companies to imple-
ment programs that foster adherence to stan-
dards of care for Medicare patients. The im-
provements in A1c and LDL testing reported
herein suggest that such a diabetes DM pro-
gram can benefit the 65 and older population.
Gender was another variable that influenced
responsiveness to the DM programs. Females
who received mail alone had lower testing rates
compared to males who received mail only.
This observation is consistent with previous
studies where females were found to be less
likely to obtain an LDL test and have ap-
propriate lipid management compared to
males.22,23 For females participating in the dia-
betes DM programs, it was only after receiving
telephonic intervention that the gender differ-
ences in A1c and LDL testing rates were re-
duced. Such findings suggest that the tele-
phonic component of a DM program may be
the key to overcoming other potential health
disparities experienced by women.
A1c and LDL testing rates varied with dis-
ease burden. Members with the greatest level
of disease burden (ie, those with the highest
RUB score) achieved the highest A1c and LDL
testing rates. This is noteworthy because im-
provement in healthy behaviors (eg, obtaining
appropriate clinical tests) is likely to result in
better control of the disease state. Interestingly,
those with the lowest RUB had the greatest per-
centage improvement in testing rates. Motivat-
ing positive behavior change in members with
less severe disease has great potential for pre-
venting or delaying the diabetes complications
that are costly in terms of dollars and quality
of life.
Limitations
Limitations of this study include using met-
rics that are less comprehensive (one or more
tests per year) than those suggested by national
guidelines and less stringent than those in-
cluded in the NCQA’s Health Plan Employer
Data and Information Set (HEDIS) Compre-
hensive Diabetes Care (CDC) measure (eg, two
or more A1c and LDL tests per year). The pur-
pose of the HEDIS CDC measure is to evaluate
the performance of health plans in fostering
member adherence to standards, whereas this
study focused on estimating the power of a DM
telephonic intervention to stimulate positive
behavior change in a large, heterogeneous di-
abetes population. Receiving just one A1c test
in this study is a proxy for the initiation of pos-
itive healthy behavior change.
An additional difference is that the HEDIS
CDC measure of adherence to clinical testing
can be calculated based on the combination of
administrative claims and medical records (ie,
chart audit) data.24 HEDIS CDC measures of
adherence are able to use medical records be-
cause they can evaluate smaller random sam-
ples of larger populations for their calculations.
In contrast, this study was more conservative
and used only administrative claims data but
focused on a much larger population. As a re-
sult, it is likely that the testing rates reported
herein are conservative estimates and the ac-
tual rates are likely to be uniformly higher.
Medical records can be a better source than ad-
ministrative claims data for measuring clinical
testing, and the combination of the two sources
provides an even more complete accounting.25
Evaluating medical records for performance of
clinical tests is often cost prohibitive, and es-
pecially so given the large sample size of this
particular study population.
Indications for further study
This study addressed several important
questions regarding the effect of telephonic DM
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interventions on members’ healthcare behav-
ior. One of the most valuable results demon-
strated the relationship between the volume of
calls and the desired behavior change in a large,
diverse diabetes population from multiple na-
tional health plans. This study also provided
insights into the differential responses of mem-
bers to telephonic intervention based on age,
gender, and disease burden.
The results also suggested indications for
further exploration, including the following:
• Statistical models representing the relation-
ship between the frequency of telephonic in-
tervention and adherence rates (ie, based on
the observed dose-response relationship).
• A targeted, prospective clinical evaluation of
whether the observed differences in age,
gender, and disease burden can guide im-
provement of intervention strategies and
whether specialized interventions for each
demographic combination would further en-
hance DM program effectiveness.
• An analysis to determine whether increases
in process measures (ie, obtaining a test) cor-
relates with improvements in the corre-
sponding clinical measures (ie, laboratory
values).
• Further evaluation of how process measures
and clinical measures are correlated with
cost savings.
CONCLUSION
This study demonstrates that telephonic in-
tervention, as part of Healthways DM pro-
grams, can successfully motivate members
with diabetes to improve their adherence to
recommended clinical testing. Because this
study was conducted with a large, diverse di-
abetes population, these findings will likely
have broad applicability across other commer-
cial health plans. The observation that testing
is influenced by gender, age, and disease bur-
den is of value in designing programs that tar-
get specific populations such as those in em-
ployer-funded health plans or Medicare health
plans. Such knowledge gives DM providers
necessary strategies for helping members mod-
ify their behaviors and improve their overall
quality of care.
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